TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -11.88%436.05M | 20.38%963.52M | 28.11%494.84M | 39.12%800.43M | 29.06%386.26M | -9.27%575.33M | 20.49%299.27M | 4.53%634.12M | 4.56%248.38M | 28.96%606.66M |
Operating income | -11.88%436.05M | 20.38%963.52M | 28.11%494.84M | 39.12%800.43M | 29.06%386.26M | -9.27%575.33M | 20.49%299.27M | 4.53%634.12M | 4.56%248.38M | 28.96%606.66M |
Operating expenses | ||||||||||
Gross profit | ||||||||||
Administrative expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---88.2M | ---160.17M |
Profit from asset sales | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --75.11M | ---- |
Employee expense | -14.34%-69.13M | -22.75%-177.77M | -0.54%-60.46M | 5.66%-144.82M | -13.45%-60.13M | -30.35%-153.51M | ---53.01M | ---117.77M | ---- | ---- |
Depreciation and amortization | 4.31%-15M | -10.04%-31.51M | -11.26%-15.68M | -25.12%-28.64M | -25.85%-14.09M | -29.17%-22.89M | ---11.2M | ---17.72M | ---- | ---- |
Impairment and provision | -559.42%-21.29M | 133.58%7.14M | 299.70%4.63M | -23.78%-21.27M | 86.01%-2.32M | -13.05%-17.18M | 1.30%-16.59M | 10.38%-15.2M | -39.78%-16.81M | 4.51%-16.96M |
-Other impairment is provision | -559.42%-21.29M | 133.58%7.14M | 299.70%4.63M | -23.78%-21.27M | 86.01%-2.32M | -13.05%-17.18M | 1.30%-16.59M | 10.38%-15.2M | -39.78%-16.81M | 4.51%-16.96M |
Operating interest expense | ---- | -47.93%-408.8M | ---- | -113.85%-276.35M | -134.53%-118.66M | -1.98%-129.23M | ---50.6M | ---126.72M | ---- | ---- |
Special items of operating profit | 6,354.55%41.18M | 94.57%-2.3M | 111.63%638K | -122.00%-42.42M | -154.18%-5.49M | 35.41%192.81M | -81.46%10.13M | 276.83%142.39M | 1,153.21%54.62M | 240.44%37.79M |
Operating profit | -12.30%371.82M | 22.08%350.28M | 128.48%423.97M | -35.57%286.93M | 4.24%185.56M | -10.77%445.34M | -34.81%178.01M | 6.80%499.1M | 35.41%273.09M | 22.87%467.32M |
Financing cost | 7.30%-185.41M | ---- | ---200.02M | ---- | ---- | ---- | ---- | ---- | -42.21%-64.32M | -21.34%-110.61M |
Share of profits of associates | 705.82%40.7M | 2,296.33%20.36M | 120.57%5.05M | -105.51%-927K | -75.94%2.29M | 14.33%16.81M | 101.14%9.52M | 246.84%14.71M | 118.37%4.73M | -9.88%4.24M |
Share of profit from joint venture company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -13.41%1.54M |
Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---126.72M | ---- | ---- |
Earning before tax | -0.83%227.1M | 29.60%370.64M | 21.90%229M | -38.12%286M | 0.17%187.85M | 19.39%462.15M | -12.17%187.53M | 6.79%387.09M | 33.32%213.51M | 22.61%362.49M |
Tax | -47.58%-61.98M | -100.75%-85.1M | -378.81%-42M | -4.21%-42.39M | 57.37%-8.77M | 18.14%-40.68M | 33.30%-20.57M | 26.24%-49.69M | 12.51%-30.85M | 19.59%-67.37M |
After-tax profit from continuing operations | -11.70%165.13M | 17.21%285.55M | 4.42%187.01M | -42.20%243.61M | 7.26%179.08M | 24.92%421.47M | -8.60%166.96M | 14.32%337.4M | 46.25%182.66M | 39.29%295.13M |
Earning after tax | -11.70%165.13M | 17.21%285.55M | 4.42%187.01M | -42.20%243.61M | 7.26%179.08M | 24.92%421.47M | -8.60%166.96M | 14.32%337.4M | 46.25%182.66M | 39.29%295.13M |
Minority profit | -19.27%9.8M | -28.54%17.3M | 11.71%12.14M | 132.11%24.21M | 70.66%10.87M | 28.07%10.43M | 84.69%6.37M | -44.91%8.14M | -43.82%3.45M | 328.09%14.78M |
Profit attributable to shareholders | -11.17%155.32M | 22.26%268.25M | 3.95%174.86M | -46.62%219.4M | 4.75%168.21M | 24.84%411.04M | -10.39%160.59M | 17.45%329.25M | 50.91%179.21M | 34.51%280.34M |
Basic earnings per share | -11.11%0.16 | 22.73%0.27 | 5.88%0.18 | -48.84%0.22 | 0.00%0.17 | 16.22%0.43 | -15.00%0.17 | 15.63%0.37 | 42.86%0.2 | 23.08%0.32 |
Diluted earnings per share | -11.11%0.16 | 22.73%0.27 | 5.88%0.18 | -48.84%0.22 | 0.00%0.17 | 16.22%0.43 | -15.00%0.17 | 15.63%0.37 | 53.85%0.2 | 23.08%0.32 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.